Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
start of a new rodeo :) ?
Well I'm the perpetual optimist & been here longer than most. I can wait a little more....
About Halftime through the contract - anyone seen anything anywhere?
On the other hand , Thanks to whoever is providing this gift - appreciate it.
You're right on. Look at the volume/buys once it was brought down in the low 20s. Pretty obvious what's going on here imo. Similar shenanigans going on with another metal resource stock from the BSGS shortage list I'm following, imo.
Brilliant !
thanks for bringing it to my attention! that was nice, ~7.30s to $10.24 in less than a month, 30+% !
Hope you didn't miss it :) ?
What a gift this is right now, IMO.
How did that work out for you ?
investing in the ~top 5 of that BGS list I mentioned earlier should be rewarding sooner or later IMO.
oh, I forgot to mention that a third explorer with one of the few promising high-grade, long life tungsten deposits outside of Cina recently got taken over as well http://almonty.com/_resources/news/nr_2015_09_11.pdf
some people are ahead of the curve :)
All just coincidence ?
I have my own theory
http://finance.yahoo.com/news/natc-announces-termination-sale-investment-200256658.html
same thing happened to malaga tungsten. gone bellyup very quickly. assets taken private/taken over by creditors.
tungsten ranking in the top 3 on the British Geologic Survey critical metals list: http://www.bgs.ac.uk/mineralsuk/statistics/riskList.html
go figure.
no mention of the shareholder meeting originally scheduled for Sep 30 (see: http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10861867 ) on the company website anymore; they gained OTC QB status again this year; wonder what's 'cooking' behind the scenes....
http://wolverinetechnologiescorp.com/investor-relations/
I would hope it gets voted down. I'll vote NO.
shareholders just approved raising the A/S from 200 to 500 mill.
SGYP short volume 25 million plus now...looks like the hedgefunds are in the business to lose money then ?
no pain data, skewed side effect profile = no partner IMO.
no partner = slim chance, if any, of competing in the marketplace for a primary care drug with an army of people promoting the first-to-market competitor, IMO.
simple as that.
rant all you want. doesn't change the fact that Phase III CIC data are out - and still no buyout & no partnership despite the "hey we're for sale" press article LOL.
that, and the low (~30%) institutional ownership of SGYP compared with IRWD (~100%), combined with the ~22 mill. short volume for SGYP speak volumes...
sooner or later the Wall Street hysteria, fanned by a couple of hyperbolic analyst op ed pieces, will be over; - the music will stop, people will wake up & valuations will adjust to reality. they always do.
I quote a comment of someone from "the trenches" posted on the IRWD CP board, who puts it in quite simple (& blunt) terms:
anonymous, Jul 22, 2015 at 9:37 AM
(quote) ...." Less diarrhea, yes but with that is less efficacy. You can't treat cic with no diarrhea and have the same efficacy. So you think you can hire a third of the reps ? So roughly 1 rep per state to grow the constipation market of 50 million? This is a primary care drug linzess has over 3000 people promoting it. When it is all said and done 80 percent of volume will come from pcp. You need a partner and despite your so called stellar efficacy and no side effects no one is stepping up. No pain data and skewed side effect data equals no partner. We developed plecanatide and linaclotide and kept linzess. I'm gonna go with the MIT scientists who discovered GCC on this one..."
http://www.cafepharma.com/boards/threads/we-should-buy-synergy.583049/
IRWD:
% of Shares Held by Institutional & Mutual Fund Owners: 110%
% of Float Held by Institutional & Mutual Fund Owners: 112%
Number of Institutions Holding Shares: 163
SGYP:
% of Shares Held by Institutional & Mutual Fund Owners: 29%
% of Float Held by Institutional & Mutual Fund Owners: 32%
Number of Institutions Holding Shares: 90
source: Yahoo finance 07/22/15
Obviousness challenge
Sgyp new short volume ~ 22 mill; - go figure ??
yet another headline to suggest it shouldn't be too hard to find funding for this technology...
United, NYSE Outages Stoke Fears About Vulnerability Of Computer Systems :
http://chicago.cbslocal.com/2015/07/08/united-nyse-outages-stoke-fears-about-vulnerability-of-computer-systems/
http://www.ft.com/cms/s/0/7c2384de-2569-11e5-bd83-71cb60e8f08c.html#axzz3fPwzJycr
have there been any funding trips to Australia/New Zealand, Europe or Japan yet ?
yes, IRWD short interest up to ~16 million shares, but SGYP up even more to about ~21.5 million shares per 06/15 :
http://www.nasdaq.com/symbol/sgyp/short-interest
the hedge funds must be in the business to lose money, I guess...
No short no loss. Let's compare notes again in a few months. Enjoy it while it lasts??
Pay back the high interest rate debt ? At least I hope so ...
no comment -
United Silver Corp. Announces the Court-Appointment of a Receiver
http://web.tmxmoney.com/article.php?newsid=64995165&qm_symbol=USCZF:US
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 9, 2014) -
see:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=99353898
and
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=104169552
oh well, it served it's purpose, I suppose :)
things are not always clear cut black and white, my friend.
I want to offer an analogy from the world I'm familiar with (biotech):
when Immunex came up with a revolutionary new anti-inflammatory drug (for rheumatoid arthritis & related indications), and, as a small biotech with VERY limited funds, was desperately looking for a development partner in the nineties, NONE of the famous & great "IBMs of the biotech world", to use an analogy, wanted to partner with them. People politely listened & gave them many reasons why it would be hopeless to try to fight a chronic condition with a biologic, and then showed them the door.
Only one, second tier company, (American Home Products at the time) had the guts & foresight to take a chance. This product (Enbrel) is now a multibillion dollar drug.
what I am trying to say is - nobody knows the future & good ideas don't always get recognized by everyone at the same time. those who have the genius & foresight to recognize a diamond in the rough BEFORE everyone else does, typically reap the largest rewards. It's like Warren Buffet once said - you can't buy what everyone else is buying & expect to do well...
correct. this is what happened to WOL* not too long ago.
got bumped from the OTC QB to the pink sheets due to missing the minimum bid requirement.
The person posting is obviously using the legalistic definition ("delisting from the tier") while conveniently neglecting to mention what the stock gets delisted TO (=pink sheets).
LOL. has the distinct, foul smell of the telemarketer logic ( insisting they only call because they want to HELP YOU SAVE MONEY)
qui bono ?
lol.
a little knowledge can be a dangerous thing.
...and into the valley of death rode the six hundred
....and it's not even difficult to look up this information:
http://finance.yahoo.com/q/mh?s=IRWD+Major+Holders
http://www.nasdaq.com/symbol/irwd/insider-trades
oh well...
Agree, quite a few people (like you & that poster) show their ignorance about share structure / numbers A vs B on public message boards
I can explain it for you, I can't understand it for you
only fools post lies that are easy to disprove:
If you had checked yahoo finance or nadaq.com, you would know he executed options:
HECHT PETER M Officer: 03/17/2015 Sell direct 125,000 at $15.6100, 4,141,417 shares owned post transaction
HECHT PETER M Officer 03/17/2015 Option Execute direct 125,000 at $1.5600, 4,266,417 shares owned post transaction
option price executed was $1.56, so those are evidently pretty old, pre-IPO options that probably came up on their expiration date.
Read more: http://www.nasdaq.com/symbol/irwd/insider-trades#ixzz3V1lqeBBv
As for share ownership (s. above, >4 million shares): to put it in perspective, the CEO of IRWD owns more shares than 141 of the 150 institutional investors in IRWD, compare:
http://www.nasdaq.com/symbol/irwd/institutional-holdings
I would encourage you to look up the CEO salaries for the CEO of IRWD, a company with a (profitable) product on the market, and the CEO of SGYP, a company with no FDA approved product, in the relevant SEC filings.
that's the real eye opener, IMHO.
Good luck !
why oh why did IRWD supposedly get a takeover bid when they only own 50% of a drug ? why not SGYP when it is much cheaper and owns 100% of the "best in class" (tongue in cheek) - oh why indeed....
if you're not reading the SGYP & IRWD message boards on Yahoo Finance on a regular basis, this article may be easily overlooked:
http://www.dailymail.co.uk/money/markets/article-3002951/MARKET-REPORT-Biopharma-takeover-mania-continues-grip-world-stockmarkets.html